| 1 | 211915-00-3 | 达比加群杂质J | Dabigatran iMpurity J | C33H39N7O5
| 对照品;达比加群酯杂质;杂质-达比加群酯;对照品-杂质对照品 | 达比加群酯杂质;对照品-杂质对照品;对照品;杂质-达比加群酯;benzimidazol;Dabigatran impurity |
| 2 | 1415901-84-6 | Dabigatran etexilate Impurity S | Dabigatran etexilate Impurity S | C33H39N7O5
| | |
| 3 | 1416446-45-1 | 3-(1-甲基-2-((((4-(N-((戊氧基)羰基)氨基甲酰氨基)苯基)氨基)甲基)-N-(吡啶-2-基)-1H-苯并[d]咪唑-5-甲酰胺基)丙酸乙酯(达比加群杂质) | Dabigatran Etexilate iMpurity C5 | C33H39N7O5
| | |
| 4 | | 5,11-Dihydro-11-[[4-[4-[2-(tert-butoxycarbonylamino)ethylaminocarbonyl]benzyl]-1-piperazinyl]acetyl]-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one | 5,11-Dihydro-11-[[4-[4-[2-(tert-butoxycarbonylamino)ethylaminocarbonyl]benzyl]-1-piperazinyl]acetyl]-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one | C33H39N7O5
| | |
| 5 | 2096992-10-6 | 达比加群酯杂质CDBA 510 BS | β-Alanine, N-[[2-[[[4-[[[(2-ethylbutoxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, methyl ester | C33H39N7O5
| 杂质-达比加群酯 | 杂质-达比加群酯 |